25.81 USD
▲+0.11+3.16%
盘后 25.03 +0.04%
2026-08-03
市值
$2.53B
市盈率
—
EPS
-6.11
股息率
—
52 周区间
18.29 – 39.89
成交量
2.10M
Beta
0.31
目标价
52.95
52W 低 18.2952W 高 39.89
价格走势
公司简介
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia; Mepsevii, an enzyme replacement therapy for the treatment...